Avatrombopag: Clinical Challenges in Thrombocytopenia Treatment and Breakthrough with New Drug
In the treatment of hematological diseases and complications related to chronic liver disease, thrombocytopenia is a common and challenging issue. It not only increases the risk of bleeding but can also delay necessary surgeries or invasive procedures. Avatrombopag (also known as avatrombopag) is a next-generation oral thrombopoietin receptor agonist (TPO-RA) that, with its unique mechanism of...
0 Bình luận
0 Chia sẻ
255 Lượt xem
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)